HI HB1316 | 2018 | Regular Session

Note: Carry Over of previous HB1316

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2017 - 25% progression, died in committee
Action: 2018-01-17 - Re-referred to HHS, JUD, referral sheet 1
Pending: House Health & Human Services Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Amends Hawaii's controlled substances act to mirror federal regulations, which permit qualified practitioners to administer, dispense, and prescribe any schedule III, IV, or V narcotic drug approved by the Food and Drug Administration for use as a detoxification treatment or maintenance treatment; provided the practitioner complies with specific federal requirements.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To The Controlled Substances Act.

Sponsors


History

DateChamberAction
2018-01-17HouseRe-referred to HHS, JUD, referral sheet 1
2017-11-30 Carried over to 2018 Regular Session.
2017-01-30HouseReferred to HLT, JUD, referral sheet 6
2017-01-25HousePass First Reading
2017-01-24HousePending introduction.

Same As/Similar To

HB1316 (Carry Over) 2017-01-30 - Referred to HLT, JUD, referral sheet 6

Subjects


Hawaii State Sources


Bill Comments

feedback